Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD).
This strategic agreement underscores Medline’s commitment to delivering unparalleled quality and innovation to its customers. Leveraging its extensive distribution network, Medline will increase the visibility of this product and enhance patient care, reduce healthcare costs and help clinicians better care for their patients.
“Medline Urology is committed to providing essential solutions that empower clinicians to reduce the risk of CAUTIs and IADs. QiVi MEC is Medline’s newest male external urine management device that bridges the needs of both infection prevention and WOC in their pursuit of lowering hospital-acquired infections. QiVi MEC helps clinicians provide their patients with quality urological care to achieve optimal outcomes. We are excited to add QiVi MEC to Medline’s robust urology portfolio,” said Mike Gerskovich, General Manager, Medline.
QiVi MEC is a unique external male urine collection device that helps to eliminate the complications of male urinary incontinence often associated with indwelling catheters, external condom sheath catheters, and absorbent pads. QiVi MEC employs suction to divert urine output in real time. The non-absorbing pouch material keeps skin dry as well as creating a highly precise fluid intake and outtake assessment. QiVi MEC is a category defining product that does away with archaic practice of absorbing urine with wicking or absorbing material. This catheter also provides ease of use for clinicians as well as keeps patient comfort in mind with its universal fit and derma-friendly, silicon-based adhesive that creates a closed system to prevent leakage.
“Our vision is to develop products that improve clinical outcomes, reduce healthcare costs, and expand coverage of use. We are incredibly excited to work with Medline to help make QiVi a standard of care across U.S. acute care hospitals,” said Nish Chasmawala, co-founder & CEO, Consure Medical. “QiVi is the only product that works effectively on patients with difficult anatomies and hospitals that have implemented QiVi have seen significant reduction in their CAUTI, IAD and HAPI rates.”
